The import of heterocyclic compounds with an unfused imidazole ring to China is forecasted to grow steadily from 2024 to 2028. The forecast begins at 3.018 million kilograms in 2024 and progresses to 3.4047 million kilograms by 2028. This indicates a consistent annual increase. The projected Compound Annual Growth Rate (CAGR) over these years is approximately 3% annually. As of 2023, the figure was slightly below 3 million kilograms, highlighting stable growth in this chemical sector.
Future trends to watch include potential changes in global supply chains, advancements in pharmaceutical technology, and shifts in China's industrial policies that could impact demand for these compounds. Monitoring these factors will be crucial for accurate forecasting and strategic planning.
